[Body composition and polycystic ovary syndrome]
- PMID: 20440089
[Body composition and polycystic ovary syndrome]
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common endocrine metabolic disorders of reproductive age women. The main signs of PCOS are as follows: androgen excess, menstrual dysfunction, infertility, obesity, and other numerous health problems. By different authors, the disorder affects 2-28% of reproductive age women. Polycystic ovary syndrome is characterized by presence of hyperandrogenism, anovulation, menstrual cycle disturbances, also by the other metabolic changes. The lack of well-defined and universally accepted diagnostic criteria makes identification of this syndrome confusing to many clinicians. There are only few studies concerning the correlations between phenotypic expression, body composition and PCOS, and relationship with the processes of growth and sexual maturation and various environmental factors (nutrition, physical activity, stress, and other factors). There is a lack of knowledge about further PCOS development and prognosis, considering the individual and environmental factors. Variation in human body composition and shape ranges considerably: many body size and shape indices (height, weight, body composition, and proportions) are the result of long evolution process and adaptation to environment. Obviously, the morphological body parameters, physiological and biochemical indices are complex and compound the interdependent system. By current literature, more than 50% of women are overweight or obese. If waist circumference and waist-to-hip ratio of women with PCOS increase, reproductive function and metabolic state of a woman is altered more than in cases when there are no changes in these parameters. The investigations of the strongest sexual dimorphism sign--the subcutaneous and visceral fat topography--showed that women with PCOS have greater adipose tissue mass in the areas of the abdomen, waist, and upper arms than control women. It is known that some indices of sexual dimorphism may be considered as the morphological signs of hyperandrogenism, for example handgrip, waist-to-hip ratio, hand and foot length, 2nd-to-4th digit (finger length) ratio (2D:4D), certain facial characteristics. Only 2D:4D ratio was investigated for the women with PCOS. The early changes of certain morphological and other indices of physical status could help to predict some metabolic characteristics, development of PCOS, and outcome of this syndrome.
Similar articles
-
Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.J Clin Endocrinol Metab. 2000 Aug;85(8):2767-74. doi: 10.1210/jcem.85.8.6738. J Clin Endocrinol Metab. 2000. PMID: 10946879 Clinical Trial.
-
Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.Hum Reprod. 2012 Nov;27(11):3279-86. doi: 10.1093/humrep/des309. Epub 2012 Aug 29. Hum Reprod. 2012. PMID: 22933528
-
Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.J Endocrinol Invest. 2004 May;27(5):424-9. doi: 10.1007/BF03345285. J Endocrinol Invest. 2004. PMID: 15279073
-
Obesity and the polycystic ovary syndrome.Int J Obes Relat Metab Disord. 2002 Jul;26(7):883-96. doi: 10.1038/sj.ijo.0801994. Int J Obes Relat Metab Disord. 2002. PMID: 12080440 Review.
-
Polycystic ovary syndrome in the Indian Subcontinent.Semin Reprod Med. 2008 Jan;26(1):22-34. doi: 10.1055/s-2007-992921. Semin Reprod Med. 2008. PMID: 18181079 Review.
Cited by
-
Effects of Hormonal Profile, Weight, and Body Image on Sexual Function in Women with Polycystic Ovary Syndrome.Healthcare (Basel). 2023 May 19;11(10):1488. doi: 10.3390/healthcare11101488. Healthcare (Basel). 2023. PMID: 37239774 Free PMC article.
-
EEG-ERP Correlates of Cognitive Dysfunction in Polycystic Ovarian Syndrome.Ann Neurosci. 2022 Oct;29(4):225-232. doi: 10.1177/09727531221115318. Epub 2022 Aug 23. Ann Neurosci. 2022. PMID: 37064285 Free PMC article.
-
Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women.J Ovarian Res. 2016 Aug 24;9(1):51. doi: 10.1186/s13048-016-0260-9. J Ovarian Res. 2016. PMID: 27557677 Free PMC article.
-
MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.Curr Med Sci. 2018 Oct;38(5):853-860. doi: 10.1007/s11596-018-1953-7. Epub 2018 Oct 20. Curr Med Sci. 2018. PMID: 30341520
-
Weight change therapy as a potential treatment for end-stage ovarian carcinoma.Am J Case Rep. 2014 May 12;15:203-11. doi: 10.12659/AJCR.890229. eCollection 2014. Am J Case Rep. 2014. PMID: 24847411 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical